Skip to main content

Table 3 Deaths prevented or postponed by medical and surgical treatments in Syria in 2006

From: Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006

TREATMENTS

Patients eligible

Treatment uptake (%)

CHD deaths prevented or postponed

Proportion of overall deaths

   

Best Estimate

Minimum estimate

Maximum estimate

Prevented or postponed (%)

Acute myocardial infarction

18002

 

285

120

540

4.5%

 Hospital resuscitation

 

0.05

13

8

23

0.2%

 Aspirin alone

 

0.96

151

62

266

2.4%

 Thrombolytic alone

 

0.59

128

53

266

2.0%

 Beta blockers

 

0.82

29

12

59

0.5%

 ACE inhibitors

 

0.74

56

23

115

0.9%

 Treatments in 1996 subtracted

  

−92

−37

−191

 

Secondary Prevention post infarction

78976

 

372

125

949

5.8%

 Aspirin

 

0.46

112

37

278

1.8%

 Beta blockers

 

0.47

125

41

310

2.0%

 ACE inhibitors

 

0.33

92

30

230

1.4%

 Statins

 

0.28

90

29

223

1.4%

 Warfarin

 

0.04

16

5

39

0.2%

 Rehabilitation

 

0.10

36

12

89

0.6%

 Treatments in 1996 subtracted

  

−97

−29

−219

 

Secondary Prevention post revascularisation (5 years)

106517

 

65

22

164

1.0%

Angina

  

803

664

2124

12.6%

 CABG surgery (1997–2006)

106517

0.10

97

-

-

1.5%

 Aspirin

319974

0.44

511

168

1273

8.0%

 Statins

319974

0.34

443

116

1322

6.9%

 Treatments in 1996 subtracted

  

−248

−75

−671

 

Treatments for unstable angina

22877

 

150

92

403

2.3%

Heart Failure with Hospital admission

6927

 

84

25

223

1.3%

 ACE inhibitors

 

0.57

41

11

122

0.6%

 Beta blockers

 

0.22

22

6

67

0.4%

 Spironolactone

 

0.49

64

21

160

1.0%

 Aspirin

 

0.80

55

18

135

0.9%

 Treatments in 1996 subtracted

  

−99

−30

−262

 

Heart failure in the community

52251

 

332

104

854

5.2%

 ACE inhibitors

  

112

29

327

1.8%

 Beta blockers

  

108

35

269

1.7%

 Spironolactone

  

226

74

563

3.6%

 Aspirin

  

97

32

240

1.5%

 Treatments in 1996 subtracted

  

−211

−66

−546

 

Hypertension Treatments

863425

 

45

8

311

0.7%

Statins for Primary Prevention

307295

 

6

2

65

0.5%

Total treatment effects*

  

2145

1165

5630

33.7%

  1. * Numbers of category totals of deaths prevented or postponed were rounded to nearest 0 or 5, totals may therefore not always sum exactly.
  2. ACE, angiotensin-converting enzyme; CABG, coronary artery bypass graft surgery.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us